Thymic changes after chorioamnionitis induced by intraamniotic lipopolysaccharide in fetal sheep - 19/08/11

Résumé |
Objective |
Regulatory T lymphocytes mediate homeostasis of the immune system and differentiate under the control of the transcription factor FoxP3 in the fetal thymus. We asked whether fetal inflammation caused by chorioamnionitis would modulate thymus development.
Study Design |
Fetal sheep were exposed to an intraamniotic injection of 10 mg lipopolysaccharide at 5 hours, 1 day, 2 days, or 5 days before delivery at 123 gestation days. Cord blood lymphocytes, plasma cortisol, and thymus weight were measured. Glucocorticoid receptor–, activated caspase-3–, Ki-67–, proliferating cell nuclear antigen–, nuclear factor-κB–, and FoxP3-positive cells were immunohistochemically evaluated in thymus.
Results |
Intraamniotic lipopolysaccharide exposure decreased the number of circulating lymphocytes by 40% after 1 day. Thymus-to-body weight ratios were reduced in all lipopolysaccharide groups by a maximum of 40% at 5 days. Lipopolysaccharide exposure modestly increased plasma cortisol concentration, increased nuclear factor-κB immunostaining in fetal thymus and reduced the number of FoxP3-positive cells by 40% at 1 day.
Conclusion |
Intraamniotic exposure to lipopolysaccharide induced thymic changes and influenced thymic FoxP3 expression.
Le texte complet de cet article est disponible en PDF.Key words : Fetal inflammatory response syndrome, FoxP3, immune response, preterm, T lymphocyte, Treg
Plan
| Cite this article as: Kunzmann S, Glogger K, Been JV, et al. Thymic changes after chorioamnionitis induced by intraamniotic lipopolysaccharide in fetal sheep. Am J Obstet Gynecol 2010;202:476.e1-9. |
|
| Supported by the Dutch Research FoundationVENI 016.096.141 (B.W.K.), the Deutsche Forschungsgemeinschaft Grant KU 1403/2-1; Interdisciplinary Center for Clinical Research, University of Würzburg, Grants IZKF Z-08 and A-58; National Heart, Lung, and Blood Institute Grant HL-65397; and the National Health and Medical Research Council, Australia (303261, 254502). |
Vol 202 - N° 5
P. 476.e1-476.e9 - mai 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
